Human T-cell lymphotropic retrovirus type III (HTLV-III), also called lymphadenopathy-
associated virus (LAV), has been identified as the aetiological agent of acquired immune …

We recently reported the isolation and characterization of a novel human T-lymphotropic
retrovirus, HTLV-III, in patients with acquired immune deficiency syndrome (AIDS) and in …

Acquired immune deficiency syndrome (AIDS) is an epidemic immunosuppressive disease
characteristically associated with a depletion of T lymphocytes of the helper/inducer …

The isolation of the human T-cell leukaemia (lymphotropic) virus type III (HTLV-III or
lymphadenopathy-associated virus) from cells of many patients with acquired immune …

Lymphadenopathy-associated virus (LAV) is a human retrovirus first isolated1 from a
homosexual patient with lymphadenopathy syndrome, frequently a prodrome or a benign …

A newly identified protein from HTLV-III/LAV, the virus implicated as the etiologic agent of the
acquired immune deficiency syndrome, was studied. This protein, which has a molecular …

Many viruses, including retroviruses, are characterized by their specific cell tropism1–3.
Lymphadenopathy-associated virus (LAV) is a human lymphotropic retrovirus isolated from …

Acquired immune deficiency syndrome (AIDS) is characterized by marked depletion of the
T4+ helper subset of T cells1–3. The aetiological agent of the disease, the human T …

The discovery that the aetiological agent of acquired immune deficiency syndrome (AIDS) is
a retro virus, referred to as human T-lymphotropic virus type III (HTLV-III) or …

The two main subgroups of the family of human T-lymphotropic retroviruses (HTLV) that
have previously been characterized are known as HTLV-I and HTLV-II. Both are associated …